Literature DB >> 23204166

Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1.

Amanda Hurley1, Mindy Smith, Tatiana Karpova, Rebecca B Hasley, Natalya Belkina, Stephen Shaw, Nariman Balenga, Kirk M Druey, Erin Nickel, Beverly Packard, Hiromi Imamichi, Zonghui Hu, Dean Follmann, James McNally, Jeanette Higgins, Michael Sneller, H Clifford Lane, Marta Catalfamo.   

Abstract

Disruption of vascular integrity by trauma and other tissue insults leads to inflammation and activation of the coagulation cascade. The serine protease thrombin links these 2 processes. The proinflammatory function of thrombin is mediated by activation of protease-activated receptor 1 (PAR-1). We found that peripheral blood effector memory CD4(+) and CD8(+) T lymphocytes expressed PAR-1 and that expression was increased in CD8(+) T cells from human immunodeficiency virus (HIV)-infected patients. Thrombin enhanced cytokine secretion in CD8(+) T cells from healthy controls and HIV-infected patients. In addition, thrombin induced chemokinesis, but not chemotaxis, of CD8(+) T cells, which led to structural changes, including cell polarization and formation of a structure rich in F-actin and phosphorylated ezrin-radexin-moesin proteins. These findings suggest that thrombin mediates cross-talk between the coagulation system and the adaptive immune system at sites of vascular injury through increased T-cell motility and production of proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23204166      PMCID: PMC3549602          DOI: 10.1093/infdis/jis730

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

Review 1.  Danger signals: SOS to the immune system.

Authors:  S Gallucci; P Matzinger
Journal:  Curr Opin Immunol       Date:  2001-02       Impact factor: 7.486

Review 2.  Essay 1: the Danger model in its historical context.

Authors:  P Matzinger
Journal:  Scand J Immunol       Date:  2001 Jul-Aug       Impact factor: 3.487

3.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

4.  Biomarkers in HIV disease.

Authors:  Jens D Lundgren; John Baxter; Steven G Deeks; H Clifford Lane
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

5.  CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.

Authors:  Marta Catalfamo; Christopher Wilhelm; Lueng Tcheung; Michael Proschan; Travis Friesen; Jung-Hyun Park; Joseph Adelsberger; Michael Baseler; Frank Maldarelli; Richard Davey; Gregg Roby; Catherine Rehm; Clifford Lane
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

Review 6.  Thrombin signalling and protease-activated receptors.

Authors:  S R Coughlin
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

7.  Invited commentary: human cytomegalovirus, inflammation, cardiovascular disease, and mortality.

Authors:  Clyde S Crumpacker
Journal:  Am J Epidemiol       Date:  2010-07-21       Impact factor: 4.897

8.  Prevalence of human herpesvirus (HHV)-8 infection among carriers of cardiovascular disease.

Authors:  F Carletti; C Mandolini; A Rossi; M R Capobianchi; M C Borgia
Journal:  J Biol Regul Homeost Agents       Date:  2002 Apr-Jun       Impact factor: 1.711

9.  Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.

Authors:  Jason V Baker; Jacqueline Neuhaus; Daniel Duprez; Lewis H Kuller; Russell Tracy; Waldo H Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Daniel E Nixon; Nicholas I Paton; James D Neaton
Journal:  J Acquir Immune Defic Syndr       Date:  2011-01-01       Impact factor: 3.731

10.  Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.

Authors:  Lotty Ledwaba; Jorge A Tavel; Paul Khabo; Patrick Maja; Jing Qin; Phumele Sangweni; Xiao Liu; Dean Follmann; Julia A Metcalf; Susan Orsega; Beth Baseler; James D Neaton; H Clifford Lane
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

View more
  21 in total

Review 1.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

2.  Modulation of γδ T-cell activation by neutrophil elastase.

Authors:  Nadia Yasmín Towstyka; Carolina Maiumi Shiromizu; Irene Keitelman; Florencia Sabbione; Gabriela Verónica Salamone; Jorge Raúl Geffner; Analía Silvina Trevani; Carolina Cristina Jancic
Journal:  Immunology       Date:  2017-10-05       Impact factor: 7.397

3.  Inflammatory Function of CX3CR1+ CD8+ T Cells in Treated HIV Infection Is Modulated by Platelet Interactions.

Authors:  Joseph C Mudd; Soumya Panigrahi; Benjamin Kyi; So Hee Moon; Maura M Manion; Souheil-Antoine Younes; Scott F Sieg; Nicholas T Funderburg; David A Zidar; Michael M Lederman; Michael L Freeman
Journal:  J Infect Dis       Date:  2016-10-04       Impact factor: 5.226

4.  A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.

Authors:  Aimee C Hodowanec; Rebecca D Lee; Kirsten E Brady; Weihua Gao; Stacey Kincaid; Jill Plants; Mieoak Bahk; Nigel Mackman; Alan L Landay; Gregory D Huhn
Journal:  BMC Infect Dis       Date:  2015-04-17       Impact factor: 3.090

Review 5.  CD8 T cell persistence in treated HIV infection.

Authors:  Joseph C Mudd; Michael M Lederman
Journal:  Curr Opin HIV AIDS       Date:  2014-09       Impact factor: 4.283

6.  Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial.

Authors: 
Journal:  Lancet HIV       Date:  2018-09-23       Impact factor: 12.767

Review 7.  Chronic HIV disease and activation of the coagulation system.

Authors:  Jason V Baker
Journal:  Thromb Res       Date:  2013-08-29       Impact factor: 3.944

Review 8.  Can early therapy reduce inflammation?

Authors:  Netanya G Sandler; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

9.  Cell type-specific mechanisms coupling protease-activated receptor-1 to infectious colitis pathogenesis.

Authors:  Alexander A Boucher; Leah Rosenfeldt; Duaa Mureb; Jessica Shafer; Bal Krishan Sharma; Adam Lane; Rebecca R Crowther; Melanie C McKell; Jordan Whitt; Theresa Alenghat; Joseph Qualls; Silvio Antoniak; Nigel Mackman; Matthew J Flick; Kris A Steinbrecher; Joseph S Palumbo
Journal:  J Thromb Haemost       Date:  2019-10-11       Impact factor: 5.824

Review 10.  Thrombin generation and activity in multiple sclerosis.

Authors:  Kelley R Jordan; Ivan Parra-Izquierdo; András Gruber; Joseph J Shatzel; Peter Pham; Larry S Sherman; Owen J T McCarty; Norah G Verbout
Journal:  Metab Brain Dis       Date:  2021-01-07       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.